Content Type: Research Publications

Strategies to Manage Drugs and Devices Approved Based on Limited Evidence: Results of a Modified Delphi Panel

March 15, 2026

Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid

March 15, 2026

Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

March 15, 2026

Barriers to US Biosimilar Market Growth: Lessons From Biosimilar Patent Litigation

March 15, 2026

FDA Regulation and Approval of Medical Devices: 1976-2020

March 15, 2026

The Timing of 30-Month Stay Expirations and Generic Entry: A Cohort Study of First Generics, 2013-2020

March 15, 2026

Reimagining Pharmaceutical Market Exclusivities: Should the Duration of Guaranteed Monopoly Periods Be Value Based?

March 15, 2026

International Reference Pricing for Prescription Drugs: A Landscape Analysis

March 15, 2026

Controversy Over Using Quality-Adjusted Life-Years in Cost-Effectiveness Analyses: A Systematic Literature Review

March 15, 2026

Regulatory and Clinical Consequences of Negative Confirmatory Trials of Accelerated Approval Cancer Drugs: Retrospective Observational Study

March 15, 2026

Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe

March 15, 2026

Cost to Medicare of Delayed Adalimumab Biosimilar Availability

March 15, 2026